Skip to main content
Top
Published in: Journal of Cancer Education 5/2020

01-10-2020 | Radiotherapy

Radiation Oncology Online: Quality, Strategies, and Disparities

Authors: Edward Christopher Dee, Nathan H. Varady

Published in: Journal of Cancer Education | Issue 5/2020

Login to get access

Abstract

Although much is known about the quality of online health information (OHI) for many malignancies, the availability of high-quality OHI for oncologic treatments remains undefined. Furthermore, search strategies that improve quality of radiation oncology OHI, and disparities in availability of high-quality OHI, are not well-described. Forty phrases describing malignancies and their treatment modalities (radiation, chemotherapy, and surgery), and 57 phrases describing radiation oncology treatments, including abbreviations for some treatments and translations in different languages, were generated. The Health on the Net Foundation framework for assessing OHI quality was applied to the top 100 websites listed for each search phrase. The availability of high-quality OHI between malignancies and treatment modalities, and among treatment modalities, was compared. The roles of radiation oncology term abbreviation, search result order, patient gender, and language, on availability of high-quality OHI, were also assessed. Among the first 10, 20, and 50 websites for each search phrase, there were significantly more high-quality websites for phrases describing malignancies compared with respective treatment modalities (P < 0.02 for all). There were no differences among treatment modalities. Among radiation oncology treatment phrases, there were no significant differences between searches for full-name phrases and their respective abbreviations, though earlier results were more likely to be of high quality. Gender did not affect quality of OHI, though language did. Availability of high-quality OHI for cancer treatments lags behind that of cancer OHI. For radiation oncology treatment OHI, search strategies and patient disparities highlight potential areas for provider intervention and increased quality of OHI.
Literature
6.
go back to reference Pai H, Lau F (2005) Web-based electronic health information systems for prostate cancer patients. Can J Urol 12:2700–2709PubMed Pai H, Lau F (2005) Web-based electronic health information systems for prostate cancer patients. Can J Urol 12:2700–2709PubMed
7.
go back to reference Jabbour J, Milross C, Sundaresan P, Ebrahimi A, Shepherd HL, Dhillon HM, Morgan G, Ashford B, Abdul-Razak M, Wong E, Veness M, Palme CE, Froggatt C, Cohen R, Ekmejian R, Tay J, Roshan D, Clark JR (2017) Education and support needs in patients with head and neck cancer: a multi-institutional survey. Cancer 123:1949–1957. https://doi.org/10.1002/cncr.30535CrossRefPubMed Jabbour J, Milross C, Sundaresan P, Ebrahimi A, Shepherd HL, Dhillon HM, Morgan G, Ashford B, Abdul-Razak M, Wong E, Veness M, Palme CE, Froggatt C, Cohen R, Ekmejian R, Tay J, Roshan D, Clark JR (2017) Education and support needs in patients with head and neck cancer: a multi-institutional survey. Cancer 123:1949–1957. https://​doi.​org/​10.​1002/​cncr.​30535CrossRefPubMed
23.
go back to reference Gaudinat A, Grabar N, Boyer C (2007) Machine learning approach for automatic quality criteria detection of health web pages. Stud Health Technol Inform 129:705–709PubMed Gaudinat A, Grabar N, Boyer C (2007) Machine learning approach for automatic quality criteria detection of health web pages. Stud Health Technol Inform 129:705–709PubMed
Metadata
Title
Radiation Oncology Online: Quality, Strategies, and Disparities
Authors
Edward Christopher Dee
Nathan H. Varady
Publication date
01-10-2020
Publisher
Springer US
Keyword
Radiotherapy
Published in
Journal of Cancer Education / Issue 5/2020
Print ISSN: 0885-8195
Electronic ISSN: 1543-0154
DOI
https://doi.org/10.1007/s13187-019-01553-y

Other articles of this Issue 5/2020

Journal of Cancer Education 5/2020 Go to the issue
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine